Herbs

Information on Lomatium

Botanical name: Lomatium dissectum.

Lomatium is native to western North America. Lomatium is potentially threatened in some parts of its habitat, so it should not be picked from the wild without consulting local experts familiar with the plant. The root of lomatium is used medicinally for infection.

Native Americans of many tribes reportedly used lomatium root to treat a wide variety of infections, particularly those affecting the lungs. Lomatium was used, particularly in the southwestern United States, during the influenza pandemic of 1917 with reportedly good results.

Active constituents: According to obscure sources, lomatium is reputed to have antiviral effects. One source suggests the constituents tetronic acids and a glucoside of luteolin may be potentially antiviral. However, little is known about how these compounds act or if other ones might be as important.

Lomatium extracts with the resins removed (often called lomatium isolates), 1–3 ml per day, have been recommended. Lomatium tincture, 1–3 ml three times per day, can also be used, but it may cause a rash in susceptible people. The tincture should not be used unless a very small amount of it is first tested for a reaction. However, even very small amounts can cause a reaction in sensitive people.

Use of lomatium extracts or tinctures containing the resin (and possibly the coumarins) can, in some people, cause a whole-body rash. This herb may also lead to nausea in some people. The safety of lomatium during pregnancy and breast-feeding is unknown and is therefore not recommended. At the time of writing, there were no well-known drug interactions with lomatium.

Leave your comments

Health News

Surgeon Removes Eight Pound Liver Tumor

The cancerous tumor in Marcus Muhich's liver weighed 8 pounds and was nearly a foot across. Doctors at three major academic medical centers in the Midwest told Muhich his high-grade tumor was inoperable. Then he was referred to Dr... [ read article ]

NIPPV Linked To Increased Hospital Mortality Rates In Small Group Of Patients

Although increased use of noninvasive positive-pressure ventilation (NIPPV) nationwide has helped decrease mortality rates among patients hospitalized with chronic obstructive pulmonary disease (COPD), a small group of... [ read article ]

FDA Approves Label Update For PREZISTA® To Include 192-Week Data In HIV-1-Infected Adult Patients

Starting Treatment Janssen Therapeutics, Division of Janssen Products, LP, announced that the U.S. Food and Drug Administration (FDA) has approved a label update for PREZISTA® (darunavir) tablets to include 192-week data from the ARTEMIS study... [ read article ]

Recommended Stuff

Our Latest Blog Entries...